-
April 2026: This Month in Huntington’s Disease Research
Latest News
-
Major Roche-Isis deal boosts Huntington's disease gene silencing
'ASO' gene silencing drugs for HD boosted by major deal between Isis Pharmaceuticals and Roche
-
HD Therapeutics Conference 2013 Updates: Day 1
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
-
Lost in translation? New insights into the making of the Huntington's disease protein
Production of normal-length & extra-long huntingtin is controlled differently. A new way to keep cells healthy in HD?
-
Simple rules for a good night's sleep in Huntington's disease
Prof Jenny Morton's simple rules for a good night's sleep in Huntington's disease
-
Is a new technique set to revolutionize Huntington's disease genetic testing?
A new genetic testing technique for HD has been reported. What does this mean for people at risk or already tested?
-
No surprises in published results from HART study of Huntexil for Huntington's disease
Data from the HART study of Huntexil for HD symptoms now published, but we still need a new, larger trial
-
Liver changes in Huntington's disease patients suggest more 'whole body' research needed
A new study suggests that liver changes may occur in HD patients, opening up new avenues of research
-
The 'N17' region of huntingtin protein: an address label in Huntington's disease?
New research sheds light on where the huntingtin protein ends up inside our cells, and why
-
HDBuzz Special Feature: Huntington's disease and sleep
Why do many Huntington's disease patients have trouble sleeping, and what can be done about it?
-
The University of New Orleans has NOT discovered a cure for Huntington's disease
The science behind an extraordinary press release claiming to have discovered 'A Way to Delay Symptoms of HD'
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
